<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">41031804</PMID><DateCompleted><Year>2025</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1715-5320</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><PubDate><Year>2025</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme</Title><ISOAbbreviation>Appl Physiol Nutr Metab</ISOAbbreviation></Journal><ArticleTitle>Effect of oat &#x3b2;-glucan in managing blood pressure: a randomized cross-over pilot trial.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>9</EndPage><MedlinePgn>1-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1139/apnm-2024-0317</ELocationID><Abstract><AbstractText>Hypertension affects over 1.2 billion adults worldwide. While numerous pharmacological treatments are available for managing hypertension, dietary approaches may also offer beneficial alternatives or complementary strategies. High molecular weight (HMW) &#x3b2;-glucan, a fibre found in oats, may be responsible for reductions in systolic blood pressure. This pilot trial investigated the efficacy of HMW oat &#x3b2;-glucan in reducing systolic and diastolic blood pressure in individuals with mild hypertension. Additionally, changes in heart rate, body weight, waist circumference, and dietary intake, including protein, carbohydrates, fat, and fibre were assessed. This study was conducted virtually during the COVID-19 pandemic. The trial followed a randomized, double-blinded, cross-over design. During the treatment period, participants were provided breakfast cookies made from oats containing 4&#xa0;g/day of HMW oat &#x3b2;-glucan. During the control period, participants received breakfast cookies made primarily from wheat, which does not contain a significant amount of &#x3b2;-glucan (0.12&#xa0;g/day). Twenty-one people completed the trial. Consumption of oat &#x3b2;-glucan breakfast cookies for 4 weeks did not reduce systolic blood pressure (132.71&#xa0;&#xb1;&#xa0;1.92&#xa0;vs. 132.9&#xa0;&#xb1;&#xa0;1.92, <i>p</i>&#xa0;=&#xa0;0.95) or diastolic blood pressure (82.86&#xa0;&#xb1;&#xa0;1.43&#xa0;vs. 82.38&#xa0;&#xb1;&#xa0;1.43, <i>p</i>&#xa0;=&#xa0;0.98) compared to control. Waist circumference (<i>p</i>&#xa0;=&#xa0;0.67), weight (<i>p</i>&#xa0;=&#xa0;0.79), heart rate (<i>p</i>&#xa0;=&#xa0;0.73), and dietary intake (protein (<i>p</i>&#xa0;=&#xa0;29), carbohydrate (<i>p</i>&#xa0;=&#xa0;0.45), fat (<i>p</i> = 12), and fibre (<i>p</i>&#xa0;=&#xa0;0.64)) were unchanged. Our results indicate that oat &#x3b2;-glucan consumption does not affect systolic or diastolic blood pressure compared to a wheat-based control in middle age and older adults with mild hypertension.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iman</LastName><ForeName>Yasmin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Seven Oaks Hospital Chronic Disease Innovation Centre, Winnipeg, MB, Canada.</Affiliation><Identifier Source="RINGGOLD">8664</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dandeneau</LastName><ForeName>Dianna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Seven Oaks Hospital Chronic Disease Innovation Centre, Winnipeg, MB, Canada.</Affiliation><Identifier Source="RINGGOLD">8664</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Haizhou</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Seven Oaks Hospital Chronic Disease Innovation Centre, Winnipeg, MB, Canada.</Affiliation><Identifier Source="RINGGOLD">8664</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mollard</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><Identifier Source="ORCID">0009-0006-3935-8730</Identifier><AffiliationInfo><Affiliation>Seven Oaks Hospital Chronic Disease Innovation Centre, Winnipeg, MB, Canada.</Affiliation><Identifier Source="RINGGOLD">8664</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>University of Manitoba, Faculty of Agriculture and Food Sciences, Department of Food and Human Nutritional Sciences, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitlock</LastName><ForeName>Reid</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Seven Oaks Hospital Chronic Disease Innovation Centre, Winnipeg, MB, Canada.</Affiliation><Identifier Source="RINGGOLD">8664</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ames</LastName><ForeName>Nancy</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Agriculture and Agri-Food Canada, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malunga</LastName><ForeName>Lovemore</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Agriculture and Agri-Food Canada, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tangri</LastName><ForeName>Navdeep</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Seven Oaks Hospital Chronic Disease Innovation Centre, Winnipeg, MB, Canada.</Affiliation><Identifier Source="RINGGOLD">8664</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>University of Manitoba, Max Rady College of Medicine, Department of Internal Medicine, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mackay</LastName><ForeName>Dylan</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-0751-1634</Identifier><AffiliationInfo><Affiliation>University of Manitoba, Faculty of Agriculture and Food Sciences, Department of Food and Human Nutritional Sciences, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Netticadan</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Agriculture and Agri-Food Canada, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thandapilly</LastName><ForeName>Sijo Joseph</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0002-5404-8443</Identifier><AffiliationInfo><Affiliation>Agriculture and Agri-Food Canada, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Appl Physiol Nutr Metab</MedlineTA><NlmUniqueID>101264333</NlmUniqueID><ISSNLinking>1715-5312</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047071">beta-Glucans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004043">Dietary Fiber</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047071" MajorTopicYN="Y">beta-Glucans</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018592" MajorTopicYN="N">Cross-Over Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018554" MajorTopicYN="Y">Avena</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="Y">Blood Pressure</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName><QualifierName UI="Q000178" MajorTopicYN="N">diet therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004043" MajorTopicYN="N">Dietary Fiber</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055105" MajorTopicYN="N">Waist Circumference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ambulatory blood pressure</Keyword><Keyword MajorTopicYN="N">beta-glucan</Keyword><Keyword MajorTopicYN="N">diastolic blood pressure</Keyword><Keyword MajorTopicYN="N">hypertension</Keyword><Keyword MajorTopicYN="N">oats</Keyword><Keyword MajorTopicYN="N">systolic blood pressure</Keyword></KeywordList><CoiStatement>The authors declare there are no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>10</Month><Day>1</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>10</Month><Day>1</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>10</Month><Day>1</Day><Hour>8</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41031804</ArticleId><ArticleId IdType="doi">10.1139/apnm-2024-0317</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>